Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - Xtant Medical Holdings, Inc. | v422140_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 15, 2015
| Xtant Medical Holdings, Inc. |
|
(Exact Name of Registrant as Specified in Its Charter)
|
| Delaware |
|
(State or Other Jurisdiction of Incorporation)
|
| 001-34951 | 20-5313323 |
| (Commission File Number) |
(IRS Employer Identification No.)
|
|
664 Cruiser Lane Belgrade, Montana |
59714 |
| (Address of Principal Executive Offices) |
(Zip Code)
|
| (406) 388-0480 | ||
|
(Registrant’s Telephone Number, Including Area Code)
| ||
|
(Former Name or Former Address, if Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| ITEM 3.01 | Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
The Company’s common stock has been approved for listing on the NYSE MKT, and the Company expects that its common stock will begin trading on the NYSE MKT under the symbol “XTNT” on October 19, 2015. Until then, the Company’s common stock will continue trading on the OTCQX marketplace under the symbol “BONE”.
| Item 7.01 | Regulation FD Disclosure. |
A copy of the press release announcing the matters described in Items 3.01 above is attached as Exhibit 99.1 and incorporated herein. The information in this Item 7.01 and the document attached as Exhibit 99.1 are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), nor otherwise subject to the liabilities of that section, nor incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
| Exhibit No | Description | |
| 99.1 | Press Release of Xtant Medical Holdings, Inc., dated October 15, 2015 entitled “Xtant Medical Holdings Announces Uplisting to NYSE MKT” |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: October 15, 2015 | XTANT MEDICAL HOLDINGS, INC. |
| By: /s/ Daniel Goldberger | |
| Name: Daniel Goldberger | |
| Title: Chief Executive Officer |
EXHIBIT INDEX
| 99.1 | Press Release of Xtant Medical Holdings, Inc., dated October 15, 2015 entitled “Xtant Medical Holdings Announces Uplisting to NYSE MKT” |